o-(chloroacetylcarbamoyl)fumagillol and Melanoma--Amelanotic

o-(chloroacetylcarbamoyl)fumagillol has been researched along with Melanoma--Amelanotic* in 1 studies

Other Studies

1 other study(ies) available for o-(chloroacetylcarbamoyl)fumagillol and Melanoma--Amelanotic

ArticleYear
Complete remission of Bomirski Ab amelanotic melanoma in hamsters treated with the angiogenesis inhibitor TNP-470.
    Neoplasma, 2002, Volume: 49, Issue:5

    The growth of solid tumors and their metastasis is dependent on the development of new blood vessels (angiogenesis). In our previous studies it was found that angiogenesis inhibitor TNP-470 acting systematically can decrease the rate of growth of transplantable Bomirski Abmelanoma in hamsters. In this study we applied TNP-470 (30 mg/kg) peritumorally from the day when tumor was palpable over 10 days, once daily. Animals were killed 6 months later and examination by autopsy and histological preparations showed the complete remission of transplanted tumor and the lack of metastasis. Thus, Ab melanoma can be effectively cured with TNP-470 angiogenesis inhibitor when the substance is applied locally.

    Topics: Angiogenesis Inhibitors; Animals; Cricetinae; Cyclohexanes; Male; Melanoma, Amelanotic; Mesocricetus; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Remission Induction; Sesquiterpenes; Time Factors

2002